See what patients really think. For any brand in your portfolio.
Run any drug or device and read the real patient conversation in seconds. Sentiment, themes, unmet needs, and how your brand stacks up against the whole class.
The stakes
The conversation that decides your launch is happening without you.
Sources: peer-reviewed patient-communication research, Edelman Trust Barometer, published adherence economics.
The blind spot
Your dashboards see the polite version. Patients tell the internet the truth.
- “I am tolerating it fine.”
- “No real side effects.”
- “I will keep taking it.”
- “The injections terrify me. I almost did not start.”
- “Down 30 lbs, but the nausea makes me want to quit.”
- “Is the immunotherapy even worth what it is doing to me?”
Why it matters
Patient sentiment is a leading indicator, not a soft metric.
Sentiment shifts weeks before it shows up in your Rx data. Read it early enough to act.
Hear what they will not tell their doctor
The fears, side effects, and second thoughts patients only admit anonymously, surfaced and themed.
Benchmark your brand against the whole class
Not your brand in isolation. Your sentiment next to every competitor, on the aspects that move share.
Find the "is it worth it?" answer
The number one predictor of starting and staying. Experiential, never clinical, and almost never in your data.
See it work
One search. The whole conversation, drawn for you.
A real read on Ozempic, drawn from public data and cited to source. Every module assembles itself the moment you search.
Cross-therapy by design. The same read runs for Ozempic, Humira, Keytruda, Dupixent, and your device.
How it works
From a name in a search box to a patient who starts.
Search any drug or device
Type a brand, a molecule, or a device. By name or by class. The report runs in seconds.
Read the real conversation
Sentiment, themes, unmet needs, FDA signal, and the full competitive class. Every number cited to where it came from.
Act on it
PatientPartner matches your patients with mentors who have been through the same therapy, turning hesitation into starts and lasting adherence.
Who it is for
Built for the people who own the number.
The real objections stalling them, and the messaging gaps competitors are quietly exploiting.
You will see: the exact phrase patients use to talk themselves out of starting.
The unspoken concerns that drive abandonment in the gap between script and first fill.
You will see: where patients quietly drop off between the script and the first fill.
Procedure anxiety and the device-choice drivers patients debate everywhere except with your reps.
You will see: the wrong-choice fear that stalls a decision for weeks.
An early signal that moves before the numbers do, so the team sees the turn coming.
You will see: sentiment turn against a rival a full quarter before the Rx data does.
Methodology and compliance
Built to clear MLR.
The unblocker, not the bottleneck. Designed with medical, legal, and regulatory review in mind from the first line of code, so your reviewers can say yes. Defensible by construction.
The public FDA adverse-event reporting system. Every safety signal we surface traces back to it.
Where patients talk candidly to each other. Sampled, usernames stripped, short excerpts only.
Structured ratings and written experiences from people on therapy, aggregated and cited to origin.
- Public data onlyNothing private, nothing scraped from behind a login.
- Short, cited excerptsUnder 20 words, never a full post reproduced.
- Usernames and PII strippedNo identity is ever surfaced, on any source.
- Every number traceableEach figure links back to where it was posted or reported.
- Aggregate, not anecdoteThemes are quantified across thousands of voices, not cherry-picked.
- Built for MLR reviewEngineered to move through medical, legal, and regulatory, not around it.
PatientPartner proof
Sentiment shows you the problem. Mentorship is how you fix it.
Across PatientPartner programs, peer mentorship turns the hesitation you just read about into starts that last.
Aggregate results across PatientPartner programs. Not drug-specific.
Stay in the loop
Get the patient-signal brief.
Where patient sentiment is moving across oncology, immunology, metabolic, devices, and rare disease, plus new PatientPulse features. No spam, unsubscribe anytime.
Work email, please. This brief is built for commercial pharma and device teams.
FAQ
The questions your reviewers will ask.
Is this compliant and MLR-ready?
Yes. PatientPulse uses public data only, shows short cited excerpts rather than full posts, strips usernames and identifying details, and traces every number back to its source. It is built to move through medical, legal, and regulatory review, not around it.
Where does the data come from?
Public sources where patients already speak candidly: FDA FAERS, public forums and Reddit, and patient review sites like Drugs.com and WebMD. Nothing private, nothing behind a login.
How is this different from review sites like WebMD?
Review sites give you scattered star ratings for one drug at a time. PatientPulse reads the conversation across your brand and the entire competitive class, themes the unmet needs, tracks the FDA signal, and cites every excerpt. It is built for a commercial team, not a patient looking up a side effect.
What does PatientPartner actually do?
PatientPartner matches your patients with trained mentors who have lived through the same therapy. Across PatientPartner programs, that peer connection turns hesitation into starts and into lasting adherence. PatientPulse shows you where the hesitation is. PatientPartner is how you close it.
How current is it?
The conversation refreshes continuously, so you read what patients are posting now, not a snapshot from last quarter. Sentiment shifts weeks before Rx data moves, and this is where you catch it.
Book a demo
See what your patients are really saying. Before your competitors do.
Run your brand and its full competitive class in a live walkthrough. Bring the molecule. We will read the room.
Public data only, anonymized and cited. Built to clear MLR. No patient data required from you.